Joon Jung

Senior Vice President, Head of Data Science Acrivon Therapeutics

Joon Jung, Ph.D., is SVP and Head, Data Science at Acrivon Therapeutics, Inc. Previously, he was the VP and Head of Data Science and Translational Discovery at Theonys where he led data science, bioinformatics, computational chemistry, biophysics and structural biology activities. From 2012-2021, Joon was the Head of Informatics & Translational Science Lead at Cyclerion Therapeutics/Ironwood Pharmaceutical. During his tenure, he developed a suite of web-based bioinformatic applications and a systems biology platform to identify novel indications by integrating -omics data, pathways and protein-protein interactome. Earlier in his career, Joon was a scientist at Merck Research Laboratories, Johnson & Johnson and Triad Therapeutics. He holds a B.S. in Electrical Engineering from the University of Illinois, a Ph.D. in Computational Chemistry from U.C. Irvine and Hebrew University, and he completed his fellowship in Bioinformatics & Computational Biology at Columbia University.

Seminars

Thursday 5th February 2026
Acrivon’s Generative Phosphoproteomics AP3 Platform Accelerates Pathway-Based Drug Design & Enables Rapid Clinical Translation
3:15 pm
  • Discuss the development of a computational pipeline and supporting infrastructure to analyze large-scale phosphoproteomics datasets and systematically characterize drug-regulated signaling network dynamics
  • Applying a proprietary generative AI model to predict kinase–substrate relationships, enabling deeper pathway interrogation
  • Utilizing these approaches to define differentiated AP3 drug response profiles and facilitate the identification of predictive biomarkers to support patient stratification and translational applications
Joon Jug